Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aida Santaolalla

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|March 19, 2020
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS StudySam Sollie, Aida Santaolalla, Dominique S Michaud, et al.
Future Oncology (London, England)|July 2, 2021
The importance of patient and public involvement in cancer research: time to create a new job profileMieke Van Hemelrijck, Vivienne Peters, John F Loong, et al.
BMC Cancer|August 30, 2019
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort studySam Sollie, Dominique S Michaud, Debashis Sarker, et al.
Ecancermedicalscience|June 11, 2025
Addressing health disparities and equitable representation in cancer research through the initiative, 'The Patient and Public Involvement Cancer Research Group for Diverse Backgrounds'Saran Green, Aida Santaolalla, Beth Russell, et al.
BJU International|October 24, 2020
Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatmentSohail Singh, Preeti Sandhu, Kerri Beckmann, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 14, 2021
Transition from esophagectomy to endoscopic therapy for early esophageal cancerJason M Dunn, Arasteh Reyhani, Aida Santaolalla, et al.
European Urology Open Science|December 22, 2021
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium DatabaseKerri Beckmann, Aida Santaolalla, Jozien Helleman, et al.
JCO Global Oncology|August 10, 2023
Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus ProcessLouis Fox, Aida Santaolalla, Jasmine Handford, et al.
Prostate Cancer and Prostatic Diseases|February 9, 2021
Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centreFrancesca Kum, Kerri Beckmann, Haleema Aya, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|March 19, 2020
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS StudySam Sollie, Aida Santaolalla, Dominique S Michaud, et al.
Future Oncology (London, England)|July 2, 2021
The importance of patient and public involvement in cancer research: time to create a new job profileMieke Van Hemelrijck, Vivienne Peters, John F Loong, et al.
BMC Cancer|August 30, 2019
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort studySam Sollie, Dominique S Michaud, Debashis Sarker, et al.
Ecancermedicalscience|June 11, 2025
Addressing health disparities and equitable representation in cancer research through the initiative, 'The Patient and Public Involvement Cancer Research Group for Diverse Backgrounds'Saran Green, Aida Santaolalla, Beth Russell, et al.
BJU International|October 24, 2020
Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatmentSohail Singh, Preeti Sandhu, Kerri Beckmann, et al.
European Radiology|March 15, 2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinomaJonathan L Moore, Manil Subesinghe, Aida Santaolalla, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 14, 2021
Transition from esophagectomy to endoscopic therapy for early esophageal cancerJason M Dunn, Arasteh Reyhani, Aida Santaolalla, et al.
European Urology Open Science|December 22, 2021
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium DatabaseKerri Beckmann, Aida Santaolalla, Jozien Helleman, et al.
JCO Global Oncology|August 10, 2023
Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus ProcessLouis Fox, Aida Santaolalla, Jasmine Handford, et al.
Prostate Cancer and Prostatic Diseases|February 9, 2021
Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centreFrancesca Kum, Kerri Beckmann, Haleema Aya, et al.
Pageof 5